Trust Stamp Inc stock skyrocketed on Wednesday after the company announced it has received Notices of Allowance from the United States Patent Office for three additional patent applications which are related to its artificial intelligence (AI)-based biometric authentication technology.
Shares of Trust Stamp had added 100% at US$3.82 at the market close on Wednesday.
Gratomic Inc (TSX-V:GRAT, OTCQX:CBULF) told investors it has completed an additional 1621.30 metres (m) of drilling on its 100% controlled Capim Gross graphite project in Brazil’s Bahia State.
The company said it has now completed 34 diamond drill holes and 4784.10m of drilling of the 5,000-meter drilling campaign.
Phunware Inc (NASDAQ:PHUN) revealed that it has joined the growing Siemens Connect Ecosystem, a network that brings together experts in software development, IT, cybersecurity, remote and digital services, and business intelligence.
"We are thrilled to collaborate with the Siemens Connect Ecosystem network to bring the power of our blue dot wayfinding technology to optimize smart buildings," said Phunware Chief Operating Officer Randall Crowder in a statement.
Iofina PLC (AIM:IOF, OTC:IOFNF) has increased production slightly in the three months to March even with cooler weather and weather-related disruption.
Output totalled 107.1 metric tonnes (MT) of crystalline iodine from its IOsorb iodine plants in Oklahoma, up 3.3 MT from the same period in 2022.
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) said the US Food and Drug Administration (FDA) has called a pre-investigational new drug (IND) meeting for 16 May 2023 to discuss a phase II/II adaptive trial study protocol for lead asset P140.
The regulator will consider a new use for the treatment: namely, chronic idiopathic demyelinating polyneuropathy (CIDP), a rare neurological disease with high medical need.
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has been issued a trademark registration for RECCE® from the Israeli Patent Office, Trademarks Department, in an effort to tap into the burgeoning Israeli pharmaceutical and biotech market.
This newly registered trademark further strengthens the company’s intellectual property portfolio with those already registered in the biggest pharmaceutical markets in the world such as Australia, USA, Europe, Japan, China and most recently in Hong Kong.
Resource drilling at Latin Resources Ltd (ASX:LRS)’s 100%-owned and fully funded Salinas Lithium Project in Brazil continues to deliver substantial results from an aggressive exploration campaign as the company heads towards a resource upgrade in June.
Drilling has confirmed the extension of the high-grade pegmatite swarm over an area of approximately one kilometre by one kilometre to a depth of 400 metres below surface.
The US patent has come through for Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF)’s novel DurAVR™ transcatheter heart valve.
The medtech company today welcomed news that the US Patent and Trademark Office has issued a utility patent for its heart valve technology.
Context Therapeutics (NASDAQ:CNTX) has announced that an abstract regarding Context’s preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody, has been selected for poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023, taking place April 14-19, 2023, at the Orange County Convention Center in Orlando, Florida. Details of the presentation are as follows - Title: Development of CTIM-76, a highly specific Claudin 6 bispecific antibody for treatment of ovarian cancer; Session Category: Immunology; Session: PO.IM01.18 - Therapeutic Antibodies 1; Abstract Number: 1865 /; Presenter: Dr Joseph Rucker, Integral Molecular; Date and Time: April 17, 2023, 9.00am-12.30pm ET; Location: Section 25.
Context also said that on Monday, April 17, 2023, at 4,30pm ET, it will host a webinar with its management team and AACR presenter, Dr Rucker, to discuss the results from this presentation and provide updates on the CTIM-76 preclinical program. Following the formal presentation, the Context team, along with Dr Rucker, will be available for questions. To register for the webinar, interested parties can use the following link: https://edisongroup.zoom.us/webinar/register/WN_bep5TKQLTlWbFPUulJFomA#/registration. Additionally, a replay of the webinar will be available on the Events page of the Investor Relations section of Context’s website for approximately 30 days after the webinar.
Lodestar Battery Metals Corp. (TSX-V:LSTR, OTCQB:SVTNF) said it has entered into an investor relations agreement with Machai Capital Inc, whereby Lodestar has retained Machai to provide digital marketing services in compliance with the policies and guidelines of the TSX Venture Exchange (TSX-V) and other applicable legislation. The engagement will commence on or about April 17, 2023, and has an initial term of six months, pursuant to which Machai will receive $100,000 in cash plus applicable taxes. The fee will be payable as follows: (i) $25,000 plus applicable taxes on the date of TSXV acceptance, (ii) $25,000 plus applicable taxes within 2 months, (iii) $25,000 plus applicable taxes within four months and (iv) $25,000 plus applicable taxes within six months. This agreement is subject to the approval of the TSX-V.
Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF) - formally Nextech AR Solutions Corp - has said it plans to release its fourth quarter and annual audited 2022 financial results after markets close on Thursday, April 20, 2023. Subsequently, Nextech will host a conference call to discuss the fourth quarter results on Thursday April 20, 2023, at 5.00pm Eastern Time, where Evan Gappelberg, the company’s CEO and Andrew Chan, its CFO will discuss the financial and operating results followed by a question and answer period. For those unable to join the live event, a recording of the presentation will be posted on the company's IR website.
AMPD Ventures Inc (CSE:AMPD, OTCQB:AMPDF) said it has launched a new, investor-focused website at http://www.ampd.ventures. Websites for the company’s subsidiaries, AMPD Technologies Inc and Departure Lounge Inc, continue to be available at http://www.ampd.tech and http://www.dlxr.ca respectively and will continue to communicate the value of each company for customers, prospective customers, partners, and other stakeholders. “Revamping our web presence to more clearly delineate our messaging to investors and our messaging to customers will help both investors and customers alike gain a clear understanding of the value of each of the companies in our group,” said James Hursthouse, CEO at AMPD Ventures in a statement. “AMPD Ventures is the public top company where we aim to create meaningful shareholder value by leveraging opportunities across the new era of immersive digital content. We are doing this by assembling a portfolio of complementary subsidiaries, each of which is focused on a key value-creation point in that ecosystem. As the world transitions to fully immersive 3D digital environments and applications, we are already seeing customer demand for the new production technologies and creative approaches offered by Departure Lounge and we are already seeing customer demand for the next-gen, high-performance computing infrastructure offered by AMPD Technologies Inc. While our subsidiaries benefit from partnering with each other, each subsidiary is designed to drive value to the AMPD group through its own independent mission and mandate.”